my account
log out
|
|
my account
log out
|
Raloxifene |
| Create: 01/16/2017 |
| Expired Date: | 04/30/2017 |
| Category: | Chemical |
| Message: | Raloxifene is indicated for the treatment and prevention of osteoporosis(bone loss) in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate |
 | |
| City: | Wuhan Hubei[CN]
 |
| Location: |
|
| Jan 19 2017 |  | Cialis(CAS NO: 171596-29-5) | 438 |
| Jan 19 2017 | | (CAS NO.:131543-23-2) Sex Enhancement Powder Sildenafil Mesylate | 448 |
| Jan 19 2017 | | Sildenafil(CAS:139755-83-2) | 420 |
| Jan 19 2017 | | 17beta-Hydroxy-1alpha-methyl-5alpha-androstan-3-one | 432 |
| Jan 19 2017 | | Mesterolone(proviron) | 443 |
| Jan 19 2017 | | Teslac | 444 |
| Jan 19 2017 | | 6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride | 470 |
| Jan 19 2017 | | Toremifene citrate | 424 |
| Jan 19 2017 | | TURINABOL,kessar | 425 |
| Jan 19 2017 | Toremifene Citrate | 441 |
| Copyright © toextrade Inc. All rights reserved. Contact us |